Viewing Company
Company Name:
Titan Medical Inc.
CIK:
840551
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2019-03-29
Last Filing Date:
2022-11-10
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2019-01-01 | 2019-12-31 | CY2019Q4I | 2020-04-02 | 0001193125-20-095558 | $ 30,689,545 | View |
| 2021-02-01 | 2021-06-30 | CY2021Q2I | 2021-08-11 | 0000891092-21-006042 | $ 11,586,000 | View |
| 2021-02-01 | 2021-09-30 | CY2021Q3I | 2021-11-12 | 0000891092-21-007275 | $ 8,632,824 | View |
| 2021-01-01 | 2021-03-31 | CY2021Q1 | 2021-05-17 | 0001580957-21-000177 | $ 1 | View |
| 2018-01-01 | 2018-12-31 | CY2018 | 2020-04-02 | 0001193125-20-095647 | $ 16,635,092 | View |
| 2018-01-01 | 2018-12-31 | CY2018Q4I | 2019-03-29 | 0001193125-19-092139 | $ 16,635,092 | View |
| 2019-04-01 | 2019-06-30 | CY2018Q2 | 2019-09-30 | 0001193125-19-258811 | $ 31,150,237 | View |
| 2019-07-01 | 2019-09-30 | CY2018Q3 | 2019-11-15 | 0001193125-19-293033 | $ 31,990,989 | View |
| 2020-04-01 | 2020-06-30 | CY2020Q2 | 2020-08-12 | 0001157523-20-001176 | $ 60,764,929 | View |
| 2020-07-01 | 2020-09-30 | CY2020Q3 | 2020-11-16 | 0001157523-20-001503 | $ 80,462,610 | View |
| 2020-01-01 | 2020-12-31 | CY2020 | 2021-04-01 | 0001157523-21-000414 | $ 67,008,897 | View |
| 2020-01-01 | 2020-12-31 | None | 2021-02-22 | 0001157523-21-000229 | $ 67,008,897 | View |
| 2021-01-01 | 2021-12-31 | CY2019Q4I | 2022-03-24 | 0000891092-22-001024 | $ 1 | View |
| 2022-04-01 | 2022-06-30 | CY2022Q2 | 2022-08-11 | 0001213900-22-046604 | $ 1,768,000 | View |
| 2022-01-01 | 2022-09-30 | CY2022Q3I | 2022-11-10 | 0001213900-22-070821 | $ 1,206,000 | View |
| 2022-01-01 | 2022-03-31 | CY2022Q1 | 2022-05-12 | 0001213900-22-025884 | $ 100,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| ifrs-full | 1862538 | None | View |
| us-gaap | Weighted Average Number of Shares, Restricted Stock | Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends. | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Weighted Average Number of Shares, Restricted Stock | View |